UltraTech Cement board to meet on July 20 for Q1FY27 results
UltraTech Cement Limited has called a Board meeting on July 20, 2026, to approve the standalone and consolidated unaudited financial results for the quarter ended June 30, 2026. The trading window for designated persons will be closed from July 1, 2026, until 48 hours after the results announcement.

*this image is generated using AI for illustrative purposes only.
UltraTech Cement Limited has scheduled a meeting of its Board of Directors for Monday, July 20, 2026, to consider and approve the standalone and consolidated unaudited financial results for the quarter ending June 30, 2026. The meeting will be conducted under Regulations 29 and 50 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
In accordance with the company's code of conduct to regulate trading by designated persons, the trading window will remain closed for all connected and designated persons and their immediate relatives. The closure period begins on July 1, 2026, and extends until 48 hours after the announcement of the financial results, ending on July 22, 2026.
Key Schedule Details
| Event | Date |
|---|---|
| Board Meeting | July 20, 2026 |
| Financial Quarter End | June 30, 2026 |
| Trading Window Closure | July 1, 2026 |
| Trading Window Reopens | July 22, 2026 |
The intimation was addressed to BSE Limited and the National Stock Exchange of India Limited, with the scrip codes 532538 and ULTRACEMCO, respectively. The notice was signed by Dhiraj Kapoor, Company Secretary and Compliance Officer.
Historical Stock Returns for UltraTech Cement
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.54% | +0.89% | +5.17% | -6.82% | -8.04% | +63.94% |
How are analysts projecting UltraTech's revenue growth for Q1 FY27 given current infrastructure demand?
What impact will recent fluctuations in coal and petcoke prices have on the company's operating margins this quarter?
Will the Board announce any capacity expansion plans or capital expenditure guidance alongside the financial results?





























